Fig. 4: Grouping of human WNV-infected human cerebral organoids. | Nature Communications

Fig. 4: Grouping of human WNV-infected human cerebral organoids.

From: A human cerebral organoid model of West Nile virus encephalitis shows innate immunocompetency

Fig. 4: Grouping of human WNV-infected human cerebral organoids.The alternative text for this image may have been generated using AI.

As the infection of human cerebral organoids with WNV resulted in heterogeneous growth kinetics, subgrouping was performed based on two factors. First, their morphology, hence the presence (ChP) or absence (Cer) of choroid plexus structures. Second, the observed course of infection. The bimodal distribution of viral peak time points (n = 30) was analyzed using a Gaussian mixture model (GMM) with two components. Type A (Early peak): μ = 3.17, σ = 0.78, weight=0.56. Type B (Late peak): μ = 11.65, σ = 2.72, weight = 0.44. Due to biological reasons, two organoids were manually assigned to Type B (for details see Methods). The resulting groups include organoids that either reached their highest viral titer until 4 dpi (Type A;) or later until 14 dpi (Type B). Partially created in BioRender. Steffen, J. F. (2026) https://BioRender.com/vufhjff. Source data are provided as a Source Data file.

Back to article page